SHEBA MEDICAL CENTER
๐ฟ๐ฆSouth Africa
- Country
- ๐ฟ๐ฆSouth Africa
- Ownership
- Private
- Established
- 1948-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sheba.co.il
Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Phase 1
- Conditions
- Rectal Neoplasms
- Interventions
- Radiation: standard dose pelvic radiation therapyDrug: standard dose capecitabineDrug: dose-escalated selinexor treatment
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2015-09-03
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT02137356
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Using Tablets for Upper Extremity Rehabilitation Post Acquired Brain Injury
Not Applicable
- Conditions
- Brain InjuryStroke
- Interventions
- Other: GRASP self exerciseDevice: Tablet - self exercise
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2014-09-18
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02136433
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Cognitive Behavioral Therapy Via a Smartphone Application on Bulimia Nervosa and Binge Eating Disorder Symptoms
Not Applicable
Withdrawn
- Conditions
- SMARTPHONE OWNERB.E.D AND BULIMIA PATIENTBASIC ENGLISH SPEAKER
- Interventions
- Behavioral: applicationOther: psychotherapy
- First Posted Date
- 2014-05-02
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Sheba Medical Center
- Registration Number
- NCT02130037
- Locations
- ๐ฎ๐ฑ
Eating Disorder Dept.Sheba Medical Center Tel Hashomer, Ramat Gan, Tel Hashomer, Israel
Multiday Fully Closed Loop Insulin Delivery in Monitored Outpatient Conditions
Not Applicable
- Conditions
- To Demonstrate That the Closed Loop System Can be Used Safely Over a Few Consecutive Days.To Assess Effectiveness in Maintaining Patients' Glucose Levels in the Target Range of 70 to 180 mg/dl, Measured by Blood Glucose Sensor.To Evaluate the User Experience With a Closed Loop System
- Interventions
- Device: Automated Ambulatory Glycemic Controller (AAGC)
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02127827
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve
Not Applicable
- Conditions
- Infertility
- Interventions
- Drug: Letrozole, GonadotropinsDrug: Gonadotropins
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT02128360
- Locations
- ๐ฎ๐ฑ
The Chaim Sheba Medical Center, Tel Hashomer, Israel
Non-Invasive Cardiac Output Measurement for CRT Optimization
Not Applicable
Completed
- Conditions
- Congestive Heart Failure
- Interventions
- Other: NICaS guided CRT optimization
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2015-08-06
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 42
- Registration Number
- NCT02126241
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia
Phase 1
Withdrawn
- Conditions
- Chronic Myeloid Leukemia
- Interventions
- Drug: BL-8040
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2016-08-15
- Lead Sponsor
- Sheba Medical Center
- Registration Number
- NCT02115672
- Locations
- ๐ฎ๐ฑ
Chaim Sheba Medical Center, Tel-Hashomer, Israel
Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS
Not Applicable
- Conditions
- Acute Coronary SyndromeSmoking Cessation
- Interventions
- Drug: VareniclineDrug: placebo
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2017-12-05
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT02106637
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation
Phase 4
Completed
- Conditions
- Pain AlleviationDilatation and EvacuationLaminaria Placement
- Interventions
- Drug: LidocaineOther: placebo comparator
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 134
- Registration Number
- NCT02097017
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
Applying the "New Authority" Model in the Treatment of Poorly Controlled Diabetic Adolescents and Their Families
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: experimental protocol treatment "The New Authority"
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2018-05-30
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02093676
- Locations
- ๐ฎ๐ฑ
Sheba Medical Center, Ramat Gan, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath